ロード中...
Dihydromyricetin ameliorates chronic liver injury by reducing pyroptosis
BACKGROUND: Chronic liver injury (CLI) is now a worldwide disease. However, there is no effective treatment. Pyroptosis plays an essential role in CLI. Dihydromyricetin (DHM) resists oxidation and protects the liver. We hypothesize that the beneficial effect of DHM on CLI is related to its effect on...
保存先:
| 出版年: | World J Gastroenterol |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Baishideng Publishing Group Inc
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7656208/ https://ncbi.nlm.nih.gov/pubmed/33244197 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v26.i41.6346 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|